blog posts

• Human trials of cancer drug PAC-1 continue with new investment

  May 24, 2016 1:00 pm by Diana YatesResearch
  • Share on Facebook
  • Tweet
  • Email

  

  Images

  • 

  The FDA also granted PAC-1 orphan drug status for the treatment of glioblastoma multiforme, a deadly brain cancer. Some steps in the approval process are aided or expedited for orphan drugs.

  stats

  additional actions
  • Share on Facebook
  • Tweet
  • Email